Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease

STAT+: Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease
ShareXFacebook

A Cytokinetics heart disease drug — already approved in one indication — succeeded in another Phase 3 trial, a potential boost for sales.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement